| PERIOD ENDING | 30-Sep-09 | 30-Jun-09 | 31-Mar-09 | 31-Dec-08 | | Total Revenue | 27,130,000 | 26,657,000 | 26,224,000 | 27,130,000 | | Cost of Revenue | 25,795,000 | 25,354,000 | 24,759,000 | 25,787,000 | | | Gross Profit | 1,335,000 | 1,303,000 | 1,465,000 | 1,343,000 | | | Operating Expenses | | Research Development |
-
|
-
| 364,000 |
-
| | Selling General and Administrative | 888,000 | 844,000 | 603,000 | 904,000 | | Non Recurring | (20,000) |
-
|
-
| 493,000 | | Others |
-
|
-
|
-
|
-
| | | | Total Operating Expenses |
-
|
-
|
-
|
-
| | | | Operating Income or Loss | 467,000 | 459,000 | 498,000 | (54,000) | | | Income from Continuing Operations | | Total Other Income/Expenses Net | 4,000 | 10,000 | (66,000) | 17,000 | | Earnings Before Interest And Taxes | 471,000 | 469,000 | 439,000 | (37,000) | | Interest Expense | 47,000 | 48,000 | 42,000 | 33,000 | | Income Before Tax | 424,000 | 421,000 | 397,000 | (70,000) | | Income Tax Expense | 123,000 | 133,000 | 116,000 | (50,000) | | Minority Interest |
-
|
-
|
-
|
-
| | | | Net Income From Continuing Ops | 301,000 | 288,000 | 281,000 | (20,000) | | | Non-recurring Events | | Discontinued Operations |
-
|
-
|
-
|
-
| | Extraordinary Items |
-
|
-
|
-
|
-
| | Effect Of Accounting Changes |
-
|
-
|
-
|
-
| | Other Items |
-
|
-
|
-
|
-
| | | | Net Income | 301,000 | 288,000 | 281,000 | (20,000) | | Preferred Stock And Other Adjustments |
-
|
-
|
-
|
-
| | | Net Income Applicable To Common Shares | $301,000 | $288,000 | $281,000 | ($20,000) |
|
0.03% Nasdaq 0.00%
Income Statement
